Recurrence and death from breast cancer after complete treatments: an experience from hospitals in Northern Thailand
- PMID: 25536710
Recurrence and death from breast cancer after complete treatments: an experience from hospitals in Northern Thailand
Abstract
Objective: To describe the pattern of disease progression and to describe locoregional recurrence, distant recurrence, and death rates in breast cancer patients after complete treatment.
Material and method: Medical records of women diagnosed with breast cancer at two university affiliated tertiary care hospitals in the Northern Thailand that had complete treatments between 2006 and 2010 were traced. Extracted key information included patient clinical profiles and documented recurrence of cancer The causes of death were verified from breast cancer case registration database, death certificates through The Ministry of Internal Affairs'civil registration, by direct telephone contact, or by distributed prepaid postcards.
Results: Medical records of 829 women diagnosed with breast cancer without prior evidence ofdistant metastasis, and had complete recommended treatment were included. Six hundred thirty seven women had not experienced any events up to the end of the follow-up (76.8%). The first occurring events were focused and categorized into three distinct types, locoregional recurrence (n = 83, median follow-up time = 34.2 months), distant recurrence (n = 78, median follow-up time = 35.4 months), and death without any evidences of locoregional or distant recurrences (n = 12, median follow-up time = 36.7 months). Distant recurrence after locoregional recurrence was reported (n = 33). There were 109 patient who had died (breast cancer related death) up to the end of the follow-up (13.2%). The three types of consecutively occurring deaths were death after locoregional recurrence without any distant recurrences (n = 15), death after distant recurrence with locoregional recurrence (n = 21), and death after documenited distant recurrence without any locoregional recurrences (n = 61).
Conclusion: The trend was that the rate of the first occurring locoregional recurrence was slightly higher than that of distant recurrence, The death rate in patients without any recurrences was much lower than in those experiencing prior recurrences. The rates of disease progression from local recurrence to distant recurrence and to death were approximately 5 to 7 times faster in patients who had experienced earlierprogressions.
Similar articles
-
[Locoregional recurrences after conservative treatment of breast cancer stage I-II].Med Clin (Barc). 2002 Feb 16;118(5):161-5. doi: 10.1016/s0025-7753(02)72321-x. Med Clin (Barc). 2002. PMID: 11851990 Spanish.
-
Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis.Lancet Oncol. 2012 Aug;13(8):802-9. doi: 10.1016/S1470-2045(12)70242-5. Epub 2012 Jun 22. Lancet Oncol. 2012. PMID: 22727222
-
Periodic follow-up after breast cancer and the effect on survival.Eur J Surg. 2001 Jul;167(7):490-6. doi: 10.1080/110241501316914849. Eur J Surg. 2001. PMID: 11560382
-
Recurrent breast cancer: treatment strategies for maintaining and prolonging good quality of life.Dtsch Arztebl Int. 2010 Feb;107(6):85-91. doi: 10.3238/arztebl.2010.0085. Epub 2010 Feb 12. Dtsch Arztebl Int. 2010. PMID: 20204119 Free PMC article. Review.
-
Local Treatment of Triple-Negative Breast Cancer.Cancer J. 2021 Jan-Feb 01;27(1):32-40. doi: 10.1097/PPO.0000000000000496. Cancer J. 2021. PMID: 33475291 Review.
Cited by
-
(-)-Oleocanthal Prevents Breast Cancer Locoregional Recurrence After Primary Tumor Surgical Excision and Neoadjuvant Targeted Therapy in Orthotopic Nude Mouse Models.Cancers (Basel). 2019 May 8;11(5):637. doi: 10.3390/cancers11050637. Cancers (Basel). 2019. PMID: 31072015 Free PMC article.
-
Individualized Prediction of Breast Cancer Survival Using Flexible Parametric Survival Modeling: Analysis of a Hospital-Based National Clinical Cancer Registry.Cancers (Basel). 2021 Mar 29;13(7):1567. doi: 10.3390/cancers13071567. Cancers (Basel). 2021. PMID: 33805407 Free PMC article.
-
Triple-negative breast cancer suppressive activities, antioxidants and pharmacophore model of new acylated rhamnopyranoses from Premna odorata.RSC Adv. 2020 Mar 12;10(18):10584-10598. doi: 10.1039/d0ra01697g. eCollection 2020 Mar 11. RSC Adv. 2020. PMID: 35492955 Free PMC article.
-
Follow-Up Strategies and Detection of Recurrent Breast Cancer in the Modern Era.Asian Pac J Cancer Prev. 2023 Apr 1;24(4):1359-1366. doi: 10.31557/APJCP.2023.24.4.1359. Asian Pac J Cancer Prev. 2023. PMID: 37116159 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical